QUOTED. 15 August 2019. Amy Abernethy.
Executive Summary
Here's what Amy Abernethy, the second-highest ranking official at the US FDA, thinks about the use of wearable devices to collect accurate patient data for clinical trials and remote monitoring.
"I continue to be somewhat of a skeptic." – Amy Abernethy, principal deputy director, US FDA
- Find out more: Top FDAer Skeptical Of Wearable Devices, Says Agency Is Working To Improve Standards And Technology
Click here for a free trial of Medtech Insight